Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 580

1.

Validation of JWH-018 and its metabolites in blood and urine by UPLC-MS/MS: Monitoring in forensic cases.

Erol Öztürk Y, Yeter O, Alpertunga B.

Forensic Sci Int. 2015 Jan 9;248C:88-93. doi: 10.1016/j.forsciint.2014.12.029. [Epub ahead of print]

PMID:
25616218
[PubMed - as supplied by publisher]
2.

Polarized cellular patterns of endocannabinoid production and detection shape cannabinoid signaling in neurons.

Ladarre D, Roland AB, Biedzinski S, Ricobaraza A, Lenkei Z.

Front Cell Neurosci. 2015 Jan 6;8:426. doi: 10.3389/fncel.2014.00426. eCollection 2014.

PMID:
25610369
[PubMed]
Free PMC Article
3.

Proapoptotic effect of endocannabinoids in prostate cancer cells.

Orellana-Serradell O, Poblete CE, Sanchez C, Castellón EA, Gallegos I, Huidobro C, Llanos MN, Contreras HR.

Oncol Rep. 2015 Jan 21. doi: 10.3892/or.2015.3746. [Epub ahead of print]

PMID:
25606819
[PubMed - as supplied by publisher]
4.

Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses.

Chiurchiù V, Leuti A, Maccarrone M.

J Neuroimmune Pharmacol. 2015 Jan 20. [Epub ahead of print]

PMID:
25601726
[PubMed - as supplied by publisher]
5.

Cannabinoid agonists rearrange synaptic vesicles at excitatory synapses and depress motoneuron activity in vivo.

García-Morales V, Montero F, Moreno-López B.

Neuropharmacology. 2015 Jan 13;92C:69-79. doi: 10.1016/j.neuropharm.2014.12.036. [Epub ahead of print]

PMID:
25595101
[PubMed - as supplied by publisher]
6.

Synthetic cannabinoid withdrawal: A new demand on detoxification services.

Macfarlane V, Christie G.

Drug Alcohol Rev. 2015 Jan 15. doi: 10.1111/dar.12225. [Epub ahead of print]

PMID:
25588420
[PubMed - as supplied by publisher]
7.

The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects.

van Amsterdam J, Brunt T, van den Brink W.

J Psychopharmacol. 2015 Jan 13. pii: 0269881114565142. [Epub ahead of print] Review.

PMID:
25586398
[PubMed - as supplied by publisher]
8.

Cannabis Concerns: Increased Potency, Availability and Synthetic Analogues.

Downey LA, Verster JC.

Curr Drug Abuse Rev. 2015 Jan 13. [Epub ahead of print] No abstract available.

PMID:
25584809
[PubMed - as supplied by publisher]
9.

»Spice« - syntetiska kannabinoider med riskabla effekter - Fall av akut njursvikt och cerebral ischemi med stroke har rapporterats.

Personne M, Westerbergh J, Hammer-Pettersen L.

Lakartidningen. 2014 Nov 18;111. pii: C7SC. Swedish.

PMID:
25584561
[PubMed - as supplied by publisher]
10.

Hallucinogens causing seizures? A case report of the synthetic amphetamine 2,5-dimethoxy-4-chloroamphetamine.

Burish MJ, Thoren KL, Madou M, Toossi S, Shah M.

Neurohospitalist. 2015 Jan;5(1):32-4. doi: 10.1177/1941874414528939.

PMID:
25553227
[PubMed]
Free PMC Article
11.

SPICE/K2 Synthetic Marijuana-Induced Toxic Hepatitis Treated with N-Acetylcysteine.

Sheikh IA, Lukšič M, Ferstenberg R, Culpepper-Morgan JA.

Am J Case Rep. 2014 Dec 30;15:584-8. doi: 10.12659/AJCR.891399.

PMID:
25548903
[PubMed - in process]
Free PMC Article
12.

Pulmonary Effects of Synthetic Marijuana: Chest Radiography and CT Findings.

Berkowitz EA, Henry TS, Veeraraghavan S, Staton GW Jr, Gal AA.

AJR Am J Roentgenol. 2014 Dec 26:1-8. [Epub ahead of print]

PMID:
25541904
[PubMed - as supplied by publisher]
13.

Neuroprotection in Experimental Autoimmune Encephalomyelitis and Progressive Multiple Sclerosis by Cannabis-Based Cannabinoids.

Pryce G, Riddall DR, Selwood DL, Giovannoni G, Baker D.

J Neuroimmune Pharmacol. 2014 Dec 24. [Epub ahead of print]

PMID:
25537576
[PubMed - as supplied by publisher]
14.

In vitro metabolism and metabolic effects of ajulemic acid, a synthetic cannabinoid agonist.

Burstein SH, Tepper MA.

Pharmacol Res Perspect. 2013 Dec;1(2):e00017. doi: 10.1002/prp2.17. Epub 2013 Dec 15.

PMID:
25505570
[PubMed]
Free PMC Article
15.

Complementary and alternative medical therapies in multiple sclerosis-the american academy of neurology guidelines: a commentary.

Yadav V, Narayanaswami P.

Clin Ther. 2014 Dec 1;36(12):1972-8. doi: 10.1016/j.clinthera.2014.10.011. Epub 2014 Nov 15.

PMID:
25467189
[PubMed - in process]
16.

Toward a translational approach to targeting the endocannabinoid system in posttraumatic stress disorder: A critical review of preclinical research.

Papini S, Sullivan GM, Hien DA, Shvil E, Neria Y.

Biol Psychol. 2015 Jan;104C:8-18. doi: 10.1016/j.biopsycho.2014.10.010. Epub 2014 Nov 4. Review.

PMID:
25448242
[PubMed - as supplied by publisher]
18.

Use of synthetic cannabinoids in patients with psychotic disorders: case series.

Celofiga A, Koprivsek J, Klavz J.

J Dual Diagn. 2014;10(3):168-73. doi: 10.1080/15504263.2014.929364.

PMID:
25392292
[PubMed - in process]
19.

»Spice« - syntetiska kannabinoider med riskabla effekter - Fall av akut njursvikt och cerebral ischemi med stroke har rapporterats.

Personne M, Westerbergh J, Hammer-Pettersen L.

Lakartidningen. 2014 Nov 11;111(47). pii: C7SC. Swedish.

PMID:
25386644
[PubMed - in process]
20.

Inhibitory effect of synthetic cannabinoids on CYP1A activity in mouse liver microsomes.

Ashino T, Hakukawa K, Itoh Y, Numazawa S.

J Toxicol Sci. 2014;39(6):815-20.

PMID:
25374372
[PubMed - in process]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk